EIPA also inhibits tumor growth in nude mouse xenografts of HCC cells, suggesting that inhibition of NHE1 could be a potential therapeutic target for the treatment of HCC (Yang et al., 2011). This evidence concerns the gene SLC9A1 and hepatocellular carcinoma.